VPS29 Activators are a distinct category of chemical compounds that directly modulate the activity of VPS29, a crucial component of the retromer complex. The retromer complex is responsible for the endosome-to-Golgi retrieval of specific transmembrane proteins, ensuring appropriate cellular localization and turnover of these proteins. Proper functioning of the retromer complex, and by extension VPS29, is integral to cellular homeostasis, playing a pivotal role in intracellular trafficking, protein recycling, and degradation processes. VPS29 activators, by design, seek to enhance or stabilize the function of VPS29, ensuring the optimization of these cellular processes.
The mode of action of VPS29 activators can be multifaceted. Some of these activators might directly bind to VPS29, stabilizing its structure and promoting its interaction within the retromer complex. Others might work indirectly, modulating upstream or downstream signaling pathways that converge on VPS29, leading to its enhanced activity. In addition to influencing protein-protein interactions within the retromer complex, certain VPS29 activators enhance the transcription or translation of the VPS29 gene, leading to an increased cellular concentration of the protein. The fine-tuning of VPS29 activity by these activators underscores the intricate nature of cellular trafficking and the importance of maintaining a balanced intracellular environment. Given the central role VPS29 plays in such processes, understanding and harnessing the abilities of these activators presents a valuable avenue for fundamental cell biology research.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By elevating cAMP levels, forskolin can impact various cellular pathways, which might include those associated with VPS29 function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
As a carboxylic ionophore antibiotic, it disrupts Golgi and endosome function, which may impact VPS29 activity. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
This compound impacts endosomal pH, which can affect retromer function and potentially VPS29. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
A disruptor of intracellular cholesterol transport, it might influence endosomal dynamics and VPS29 activity. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
It affects actin polymerization, potentially impacting endosomal dynamics and VPS29 function. |